You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

CLINICAL TRIALS PROFILE FOR PIMOZIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for PIMOZIDE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00004652 ↗ Phase II Pilot Controlled Study of Short Vs Longer Term Pimozide (Orap) Therapy in Tourette Syndrome Completed University of Rochester Phase 2 1993-02-01 OBJECTIVES: I. Determine whether the time period between randomization and endpoint is longer in the short term pimozide therapy or longer term therapy in patients with Tourette syndrome. II. Determine whether tic severity, medication side effects, academic performance and psychosocial functioning are better in the short term pimozide therapy or longer term pimozide therapy.
NCT00004652 ↗ Phase II Pilot Controlled Study of Short Vs Longer Term Pimozide (Orap) Therapy in Tourette Syndrome Completed National Center for Research Resources (NCRR) Phase 2 1993-02-01 OBJECTIVES: I. Determine whether the time period between randomization and endpoint is longer in the short term pimozide therapy or longer term therapy in patients with Tourette syndrome. II. Determine whether tic severity, medication side effects, academic performance and psychosocial functioning are better in the short term pimozide therapy or longer term pimozide therapy.
NCT00158223 ↗ Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia Completed National Institute of Mental Health (NIMH) Phase 4 2004-10-01 This study will assess the effectiveness of pimozide in enhancing the effects of clozapine in the treatment of schizophrenia.
NCT00158223 ↗ Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia Completed Icahn School of Medicine at Mount Sinai Phase 4 2004-10-01 This study will assess the effectiveness of pimozide in enhancing the effects of clozapine in the treatment of schizophrenia.
NCT00289861 ↗ Risperidone Augmentation in Patients With Schizophrenia Completed Stanley Medical Research Institute Phase 4 2003-02-01 We propose a double-blind, placebo-controlled trial to study the effectiveness and tolerability of adding risperidone to stable yet only partially remitted patients with schizophrenia maintained on clozapine.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for PIMOZIDE

Condition Name

Condition Name for PIMOZIDE
Intervention Trials
Schizophrenia 7
Psychotic Disorders 2
Stress Disorders, Post-Traumatic 2
Drug-induced QT Prolongation 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for PIMOZIDE
Intervention Trials
Schizophrenia 7
Psychotic Disorders 4
Mental Disorders 3
Disease 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for PIMOZIDE

Trials by Country

Trials by Country for PIMOZIDE
Location Trials
United States 35
Spain 9
Canada 7
United Kingdom 2
Germany 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for PIMOZIDE
Location Trials
New York 5
California 3
Connecticut 2
North Carolina 2
New Mexico 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for PIMOZIDE

Clinical Trial Phase

Clinical Trial Phase for PIMOZIDE
Clinical Trial Phase Trials
Phase 4 3
Phase 3 2
Phase 2 7
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for PIMOZIDE
Clinical Trial Phase Trials
Completed 12
Not yet recruiting 3
Withdrawn 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for PIMOZIDE

Sponsor Name

Sponsor Name for PIMOZIDE
Sponsor Trials
University of Calgary 2
Stanley Medical Research Institute 2
VA Office of Research and Development 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for PIMOZIDE
Sponsor Trials
Other 30
U.S. Fed 6
NIH 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.